Advancing Telemedicine in Pulmonology: Acoustic-waveform Respiratory Evaluation (AWARE) Via Sensing and Machine Learning on Smartphones
Indiana University
Summary
The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.
Description
Asthma and COPD respectively affect millions of people in the US. Chronic lower respiratory diseases represented the fourth leading cause of death in the country before the pandemic. For these and other pulmonary diseases like cystic fibrosis (CF), monitoring disease remotely but objectively could lead to marked improvements in disease control, quality of life, and overall prognosis. However, current disease monitoring and management often rely on subjective symptom report, and objective pulmonary function tests (PFTs) are often only done a handful of times a year at subspecialty referral cent…
Eligibility
- Age range
- 8–70 years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: 1. Age 8-70 years 2. Ability to perform spirometry and oscillometry 3. Signed informed consent (and assent for children as appropriate) 4. No respiratory or other major disease (for healthy controls), or physician-diagnosed asthma, COPD, CF, or other airway diseases Exclusion Criteria: 1. Inability or unwillingness to perform AWARE, spirometry, or oscillometry 2. Acute or chronic illness that, at the judgement of investigators, may affect lung function and alter the results of AWARE or the reference PFTs (spirometry and AOS)
Interventions
- Diagnostic TestAWARE
AWARE testing to estimate lung function and aid in disease diagnosis
Locations (2)
- Indiana UniversityIndianapolis, Indiana
- University of PittsburghPittsburgh, Pennsylvania